Skip to main content

Table 3 Factors associated with CD8+ T cells secreting cytokines in the univariate and multivariate linear regression analysis

From: Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B

Variable

CD8_IFN-γ

CD8_TNF-α

CD8_IL-2

Univariate (raw effects)

Multivariate (adjusted effects)

Univariate (raw effects)

Multivariate (adjusted effects)

Univariate (raw effects)

Multivariate (adjusted effects)

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

B (95% CI)

P

Adjusted B (95% CI)

Adjusted P

Age (≥ 25 vs <  25 years)

8.08 (1.79, 14.36)

0.012

6.92 (0.41, 13.43)

0.037

8.2 (1.04, 15.37)

0.025

6.89 (−0.59, 14.37)

0.071

0.11 (− 0.36, 0.58)

0.635

0.09 (− 0.42, 0.59)

0.729

Gender (Male ve Female)

5.25 (−0.69, 11.2)

0.083

3.36 (−2.7, 9.41)

0.275

5.41 (− 1.35, 12.17)

0.116

3.81 (−3.15, 10.77)

0.281

0.22 (−0.22, 0.65)

0.334

0.13 (−0.34, 0.6)

0.586

Family History (Yes vs No)

−1.42 (−6.86, 4.02)

0.607

−3.27 (−9.39, 2.86)

0.293

−0.56 (− 6.75, 5.62)

0.858

−2.22 (− 9.26, 4.82)

0.534

0.01 (− 0.38, 0.41)

0.943

−0.03 (− 0.5, 0.44)

0.903

Vertical Transmission (Yes vs No)

−0.84 (−8.24, 6.57)

0.824

1.82 (− 6.43, 10.08)

0.663

− 0.85 (− 9.26, 7.55)

0.841

0.72 (− 8.77, 10.2)

0.881

− 0.01 (− 0.56, 0.53)

0.961

−0.03 (− 0.67, 0.61)

0.931

Infection Time (≥ 20 vs <  20 years)

4.76 (− 2.88, 12.4)

0.220

0.97 (− 7, 8.94)

0.810

6.1 (− 2.56, 14.75)

0.166

2.69 (− 6.47, 11.86)

0.562

− 0.08 (− 0.65, 0.48)

0.769

− 0.16 (− 0.77, 0.46)

0.616

Log HBsAg

− 0.021 (− 0.033, − 0.009)

0.001

−0.2 (− 4.62, 4.23)

0.931

0.54 (− 4, 37, 5.44)

0.829

0.98 (− 4.11, 6.07)

0.704

0.08 (− 0.24, 0.40)

0.621

0.01 (− 0.33, 0.36)

0.938

Log HBV DNA

−0.054 (− 0.087, − 0.021)

0.001

−2.08 (− 4.35, 0.2)

0.073

−0.12 (− 1.37, 1.12)

0.849

−1.59 (− 4.2, 1.03)

0.232

0.26 (− 0.2, 0.72)

0.260

− 0.06 (− 0.24, 0.11)

0.483

HBeAg (Positive vs Negative)

−2.35 (− 7.78, 3.08)

0.394

3.87 (− 5.24, 12.97)

0.402

− 1.37 (− 7.54, 4.81)

0.662

2.98 (−7.48, 13.45)

0.574

− 0.22 (− 0.62, 0.17)

0.266

− 0.01 (− 0.72, 0.69)

0.969

ALT (<  2 ULN is the reference group)

 ≥ 2 & < 5 ULN

10.78 (3.81, 17.75)

0.003

12.5 (4.87, 20.13)

0.002

12.08 (4.18, 19.99)

0.003

13.05 (4.29, 21.82)

0.004

−0.14 (− 0.67, 0.38)

0.594

− 0.05 (− 0.64, 0.54)

0.859

 ≥ 5ULN

2.77 (−5.9, 11.45)

0.528

4.93 (−4.61, 14.48)

0.309

5.47 (− 4.38, 15.31)

0.274

6.68 (−4.29, 17.65)

0.230

0.20 (−0.45, 0.86)

0.539

0.23 (−0.51, 0.97)

0.533

Genotype (Genotype C is the reference group)

 B

−3.57 (−10.39, 3.24)

0.302

−2.42 (−9.2, 4.36)

0.481

−6.27 (−16.8, 4.25)

0.240

− 3.21 (− 11, 4.58)

0.417

−0.52 (− 1.02, − 0.03)

0.039

− 0.49 (− 1.02, 0.03)

0.067

 N

− 3.71 (− 12.99, 5.56)

0.430

− 10.05 (− 21.31, 1.22)

0.080

−8.65 (− 21.77, 4.47)

0.195

−10.2 (− 23.15, 2.74)

0.121

− 0.36 (− 1.04, 0.31)

0.288

−0.59 (− 1.46, 0.28)

0.184

 O

− 8.44 (− 20.01, 3.13)

0.152

−7.3 (− 18.92, 4.32)

0.216

− 4.83 (− 12.56, 2.9)

0.219

− 6.66 (− 20.01, 6.7)

0.326

− 0.68 (− 1.52, 0.16)

0.113

− 0.64 (− 1.54, 0.26)

0.161

  1. Significant values are shown in boldface. B: Unstandardized Coefficients. HBV genotype: Other included C + D, B + D, B + C, D; N, not detected
  2. ALT alanine aminotransferase, HBeAg HBV e antigen, HBsAg hepatitis B surface antigen;